ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: paclitaxel albumin-stabilized nanoparticle formulation
Sponsor: Premiere Oncology